(S)-3-Methylamino-pyrrolidine-1-carboxylic acid tert-butyl ester, 95.0%, 10g

2-METHYL-1,4-NAPHTHOHYDROQUINONE, 95.0%, 10mg

2-(2-Nitroanilino)ethanol>98.0%(GC)5g

N-bromosuccinimida, mínimo 98 %, para síntesis, 500 g, envase de vidrio

1-METHYL-1H-PYRROLO[2,3-B]PYRIDIN-6-AMINE, 95.0%, 250mg

3-Ethylpyridine, 95.0%, 5g

Prednisone, 97.0%, 5g

4-Fluoro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-amine, 98+%, 250mg

(2E)-1-(4-bromophenyl)-3-(2-methylphenyl)prop-2-en-1-one, 95.0%, 10g

1-(4-Vinylbenzyl)-1H-imidazole, 95.0%, 10g

(S)-(+)-Ketopinic acid, 98.0%, 2.5g

2,6-Dichloro-4-(dimethylamino)nicotinaldehyde, 97%, 250mg

Lansoprazole>98.0%(HPLC)(T)1g